logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
T

Tine Kold Olesen

assistance publique hopitaux paris (aphp)

16H指数
53论文数
2.2K被引数
收录论文 18
发表时间
logo
Follicle-stimulating hormone receptor expression in advanced atherosclerotic plaques卵泡刺激素受体在晚期动脉粥样硬化斑块中的表达
errSCIENTIFIC REPORTS
IF3.9
err2024-05-03
err1
errOAAI
errGhinea, Nicolae; Liehn, Elisa Anamaria; Grommes, Jochen; Delattre, Diane Dalila; Olesen, Tine Kold
err分享
err收藏
Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer The Primary Results of the PRONOUNCE Randomized TrialDegarelix与亮丙瑞林在前列腺癌患者中的心血管安全性PRONOUNCE随机试验的主要结果
errCIRCULATION
IF38.6
err2021-10-19
err113
errOAAI
errLopes, Renato D.; Higano, Celestia S.; Slovin, Susan F.; Nelson, Adam J.; Bigelow, Robert; Sorensen, Per S.; Melloni, Chiara; Goodman, Shaun G.; Evans, Christopher P.; Nilsson, Jan; Bhatt, Deepak L.; Clarke, Noel W.; Olesen, Tine K.; Doyle-Olsen, Belinda T.; Kristensen, Henriette; Arney, Lauren; Roe, Matthew T.; Alexander, John H.
err分享
err收藏
Assessment of the Most Impactful Combination of Factors Associated with Nocturia and to Define Nocturnal Polyuria by Multivariate Modelling
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2020-07-16
err6
errOAAI
errOlesen, Tine; Paul, Jerome; Gramme, Pierre; Drake, Marcus J.; Vandewalle, Johan; Everaert, Karel
err分享
err收藏
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer The PRONOUNCE Trial Study Design
errJACC: CARDIOONCOLOGY
IF12.8
err2020-03-01
err38
errOAAI
errMelloni, Chiara; Slovin, Susan F.; Blemings, Allan; Goodman, Shaun G.; Evans, Christopher P.; Nilsson, Jan; Bhatt, Deepak L.; Zubovskiy, Konstantin; Olesen, Tine K.; Dugi, Klaus; Clarke, Noel W.; Higano, Celestia S.; Roe, Matthew T.
err分享
err收藏
Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
errEUROPEAN UROLOGY
IF25.2
err2014-03-01
err287
PREAI
errAlbertsen, Peter C.; Klotz, Laurence; Tombal, Bertrand; Grady, James; Olesen, Tine K.; Nilsson, Jan
err分享
err收藏
ANDROGEN DEPRIVATION THERAPY BY A GONADOTROPIN RELEASING HORMONE ANTAGONIST, DEGARELIX, LOWERS THE RISK OF CARDIOVASCULAR EVENTS OR DEATH WHEN COMPARED TO LUTEINISING HORMONE-RELEASING AGONISTS
errJOURNAL OF UROLOGY
IF6.8
err2013-04-01
err4
PREAI
errAlbertsen, Peter; Tombal, Bertrand; Wiegel, Thomas; van der Meulen, Egbert; Persson, Bo-Eric; Olesen, Tine Kold; Beckman, Joshua
err分享
err收藏
Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses
errCLINICAL CHEMISTRY AND LABORATORY MEDICINE
IF3.7
err2012-07-05
err8
errOAAI
errUlmert, David; Vickers, Andrew J.; Scher, Howard I.; Becker, Charlotte; Iversen, Peter; Frankel, David; Jensen, Jens-Kristian; Olesen, Tine Kold; Lilja, Hans
err分享
err收藏
A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate Cancer
errJOURNAL OF UROLOGY
IF6.8
err2011-09-01
err129
PREAI
errCrawford, E. David; Tombal, Bertrand; Miller, Kurt; Boccon-Gibod, Laurent; Schroeder, Fritz; Shore, Neal; Moul, Judd W.; Jensen, Jens-Kristian; Olesen, Tine Kold; Persson, Bo-Eric
err分享
err收藏
Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer
errJOURNAL OF UROLOGY
IF6.8
err2010-12-01
err76
errOAAI
errSmith, Matthew R.; Klotz, Laurence; Persson, Bo-Eric; Olesen, Tine Kold; Wilde, Arthur A. M.
err分享
err收藏
Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study
errBJU INTERNATIONAL
IF4.4
err2010-06-18
err60
errOAAI
errSchroder, Fritz H.; Tombal, Bertrand; Miller, Kurt; Boccon-Gibod, Laurent; Shore, Neal D.; Crawford, E. David; Moul, Judd; Olesen, Tine Kold; Persson, Bo-Eric
err分享
err收藏
Additional Analysis of the Secondary End Point of Biochemical Recurrence Rate in a Phase 3 Trial (CS21) Comparing Degarelix 80 mg Versus Leuprolide in Prostate Cancer Patients Segmented by Baseline Characteristics一项3期试验 (CS21) 中生化复发率次要终点的额外分析，比较地加瑞克80 mg与亮丙瑞林在前列腺癌患者中的基线特征
errEUROPEAN UROLOGY
IF25.2
err2010-05-01
err127
PREAI
errTombal, Bertrand; Miller, Kurt; Boccon-Gibod, Laurent; Schroeder, Fritz; Shore, Neal; Crawford, E. David; Moul, Judd; Jensen, Jens-Kristian; Olesen, Tine Kold; Persson, Bo-Eric
err分享
err收藏
PROSTATE-SPECIFIC ANTIGEN AND SERUM ALKALINE PHOSPHATASE LEVELS IN PROSTATE CANCER PATIENTS RECEIVING DEGARELIX OR LEUPROLIDE
errJOURNAL OF UROLOGY
IF6.8
err2010-04-01
err2
PREAI
errCrawford, E. David; Moul, Judd W.; Shore, Neal D.; Olesen, Tine Kold; Persson, Bo-Eric
err分享
err收藏
CARDIOVASCULAR SAFETY OF DEGARELIX: RESULTS FROM A 12-MONTH, COMPARATIVE, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP PHASE III TRIAL IN PROSTATE CANCER PATIENTS
errJOURNAL OF UROLOGY
IF6.8
err2010-04-01
err2
PREAI
errKlotz, Laurence; Smith, Matthew; Persson, Bo-Eric; Olesen, Tine Kold; Wilde, Arthur
err分享
err收藏
SWITCHING FROM LEUPROLIDE TO DEGARELIX VS CONTINUOUS DEGARELIX TREATMENT - EFFECTS ON LONG-TERM PROSTATE-SPECIFIC ANTIGEN CONTROL
errJOURNAL OF UROLOGY
IF6.8
err2010-04-01
err9
PREAI
errCrawford, E. David; Moul, Judd W.; Shore, Neal D.; Olesen, Tine Kold; Persson, Bo-Eric
err分享
err收藏
Degarelix: A New Approach for the Treatment of Prostate Cancer
errNEUROENDOCRINOLOGY
IF2.8
err2009-07-14
err21
PREAI
errPersson, Bo-Eric; Olesen, Tine Kold; Jensen, Jens-Kristian
err分享
err收藏
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
errBJU INTERNATIONAL
IF4.4
err2008-11-21
err494
PREAI
errKlotz, Laurence; Boccon-Gibod, Laurent; Shore, Neal D.; Andreou, Cal; Persson, Bo-Eric; Cantor, Per; Jensen, Jens-Kristian; Olesen, Tine Kold; Schroeder, Fritz H.
err分享
err收藏
A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America
errJOURNAL OF UROLOGY
IF6.8
err2008-11-01
err101
PREAI
errGittelman, Marc; Pommerville, Peter J.; Persson, Bo-Eric; Jensen, Jens-Kristian; Olesen, Tine Kold
err分享
err收藏
Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker-Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate CancerDegarelix: 一种新型促性腺激素释放激素 (GnRH) 受体阻滞剂-来自一项为期1年，多中心，随机，2期剂量发现的前列腺癌治疗研究的结果
errEUROPEAN UROLOGY
IF25.2
err2008-10-01
err110
PREAI
errVan Poppel, Hendrik; Tombal, Bertrand; de la Rosette, Jean J.; Persson, Bo-Eric; Jensen, Jens-Kristian; Olesen, Tine Kold
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
Deepak L. Bhatt
H 指数: 197 · 论文数: 3.7K
H
Howard I. Scher
H 指数: 164 · 论文数: 1.4K
A
Arthur A.M. Wilde
H 指数: 149 · 论文数: 1.2K
A
Andrew J. Vickers
H 指数: 127 · 论文数: 1.4K
R
Renato D. Lópes
H 指数: 115 · 论文数: 1.3K
查看更多